G01N 33/5767
Non-a, non-b hepatitis
Official title: {non-A, non-B hepatitis}
G01N33/5767 (Non-a, non-b hepatitis) appears on 212 US grants and 296 published applications in this corpus.
Search patents in G01N- Granted patents
- 212
- Published applications
- 296
- Assignees
- 197
- Inventors
- 674
- Latest grant
- 10 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 7 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 14 | 0 |
| 1999 | 5 | 0 |
| 2000 | 11 | 0 |
| 2001 | 13 | 3 |
| 2002 | 9 | 19 |
| 2003 | 8 | 28 |
| 2004 | 8 | 22 |
| 2005 | 4 | 14 |
| 2006 | 10 | 19 |
| 2007 | 7 | 7 |
| 2008 | 13 | 23 |
| 2009 | 4 | 8 |
| 2010 | 11 | 25 |
| 2011 | 4 | 13 |
| 2012 | 4 | 13 |
| 2013 | 6 | 14 |
| 2014 | 9 | 14 |
| 2015 | 3 | 7 |
| 2016 | 6 | 11 |
| 2017 | 6 | 9 |
| 2018 | 9 | 6 |
| 2019 | 8 | 11 |
| 2020 | 3 | 8 |
| 2021 | 5 | 7 |
| 2022 | 4 | 7 |
| 2023 | 1 | 4 |
| 2024 | 2 | 1 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for preparing multimeric forms of the hepatitis c virus (HCV) envelope glycoprotein 2 (HCV E2)10 Dec 2024US 12,162,906 B2Macfarlane Burnet Institute for Medical Research and Public Health Limited
- Method and means for diagnosing autoimmune hepatitis using autoantibody markers23 Jul 2024US 12,044,682 B2Medizinische Hochschule Hannover
- Multi-targeted fibrosis tests14 Mar 2023US 11,605,460 B2Centre Hospitalier Universitaire D'Angers
- Method for detecting whether glucose metabolism is abnormal, and prevention and treatment therefor13 Sep 2022US 11,439,689 B2Kaohsiung Medical University
- Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies30 Aug 2022US 11,428,694 B2Abbott Laboratories
- Hcv antigens and antibodies19 Mar 2026US 2026/0078172 A1The Johns Hopkins University
- Assembled glycoproteins3 Jul 2025US 2025/0215048 A1Macfarlane Burnet Institute for Medical Research and Public Health Limited
- Methods and systems for diagnosing orthopoxvirus infection8 May 2025US 2025/0147043 A1
- Thermally responsive partitions for devices and systems and methods of using same12 Dec 2024US 2024/0410883 A1
- Hepatitis e virus orf2 capsid polypeptides and uses thereof26 Oct 2023US 2023/0340030 A1Centre Hospitalier Regional Universitaire De Lille
Most cited
By later US patents
- HCV immunoassays employing C domain antigens147US 5,350,671 AChiron Corporation · 1994
- Process, device and reagent for cell separation97US 7,316,897 B2L'Assistance Publique, Hopitaux de Paris (AP-HP) · 2008
- Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies71US 5,683,864 AChiron Corporation · 1997
- Optical disk-based assay devices and methods65US 6,342,349 B12002
- NANBV Diagnostics and vaccines58US 6,027,729 AChiron Corporation · 2000